Suppr超能文献

使用诱导型半胱天冬酶-9自杀保障系统结合诱导多能干细胞和生物发光追踪技术。

Using the Inducible Caspase-9 Suicide-Safeguard System with iPSC and Bioluminescent Tracking.

作者信息

Villanueva Jonathan, Nishimura Toshinobu, Nakauchi Hiromitsu

机构信息

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Methods Mol Biol. 2019;2048:259-264. doi: 10.1007/978-1-4939-9728-2_20.

Abstract

For scientists working within the field of induced pluripotent stem cells (iPSCs), this protocol will provide a thorough walk-through on how to conduct in vitro and in vivo experiments that validate the function of a particular safeguard system technology. In short, we provide instructions on how to generate inducible Caspase-9 (iC9) safeguard system with human iPSCs that act as normal or abnormal models of the cells for therapeutics to be tried after differentiation. These iC9-iPSCs should be modified prior to beginning this protocol by constitutively expressing luciferase, an enzyme capable of generating bioluminescent signals through the oxidation of the substrate luciferin. Monitoring the bioluminescent signal over time provides the information on whether a safeguard system is working or not.

摘要

对于在诱导多能干细胞(iPSC)领域工作的科学家而言,本方案将全面介绍如何进行体外和体内实验,以验证特定保障系统技术的功能。简而言之,我们提供了有关如何利用人类iPSC生成诱导型Caspase-9(iC9)保障系统的说明,这些iPSC可作为正常或异常细胞模型,用于分化后待试验治疗方法。在开始本方案之前,这些iC9-iPSC应通过组成型表达荧光素酶进行修饰,荧光素酶是一种能够通过底物荧光素的氧化产生生物发光信号的酶。随着时间的推移监测生物发光信号可提供保障系统是否起作用的信息。

相似文献

1
Using the Inducible Caspase-9 Suicide-Safeguard System with iPSC and Bioluminescent Tracking.
Methods Mol Biol. 2019;2048:259-264. doi: 10.1007/978-1-4939-9728-2_20.
2
Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
Stem Cells Transl Med. 2017 Feb;6(2):382-393. doi: 10.5966/sctm.2016-0201. Epub 2016 Sep 7.
3
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells.
Mol Ther. 2015 Sep;23(9):1475-85. doi: 10.1038/mt.2015.100. Epub 2015 May 29.
5
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.
Stem Cell Reports. 2015 Oct 13;5(4):597-608. doi: 10.1016/j.stemcr.2015.07.011. Epub 2015 Aug 28.
8
High-Throughput Firefly Luciferase Reporter Assays.
Methods Mol Biol. 2018;1755:19-29. doi: 10.1007/978-1-4939-7724-6_2.
9
Conditional Genetic Ablation Mouse Models as a Tool to Study Cancer Immunosurveillance In Vivo.
Methods Mol Biol. 2019;1884:161-176. doi: 10.1007/978-1-4939-8885-3_11.
10
Using Bioengineered Bioluminescence to Track Stem Cell Transplantation In Vivo.
Methods Mol Biol. 2020;2126:1-11. doi: 10.1007/978-1-0716-0364-2_1.

引用本文的文献

1
Enabling allogeneic therapies: CIRM-funded strategies for immune tolerance and immune evasion.
Stem Cells Transl Med. 2020 Sep;9(9):959-964. doi: 10.1002/sctm.20-0079. Epub 2020 Jun 25.
2
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells.
iScience. 2020 Jun 26;23(6):101162. doi: 10.1016/j.isci.2020.101162. Epub 2020 May 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验